Arix Bioscience (ARIX) News Today GBX 142 0.00 (0.00%) (As of 02/12/2024) Add Compare Share Share Headlines Stock AnalysisHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period ARIX/USD - Arix US DollarAugust 18, 2024 | investing.comEconomy Minister Jeremy Miles on business support, entrepreneurship and the development bankMay 22, 2024 | msn.comSphere Fluidics Appoints Edward Rayner as Non-Executive DirectorApril 17, 2024 | finance.yahoo.comArix Bioscience PLC (3HY.SG)April 9, 2024 | finance.yahoo.comLife sciences firm ReNeuron which received £13m in Welsh Government support enters administrationMarch 22, 2024 | msn.comAcacia Research: Positive Developments, Discount To Book Value High Despite Recent Price SpikeMarch 18, 2024 | seekingalpha.comAcacia Research Corporation (NASDAQ:ACTG) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comSuspension of Trading in SharesFebruary 12, 2024 | markets.businessinsider.comArix Bioscience PLC: Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)January 9, 2024 | finanznachrichten.deArix Bioscience PLC: Portfolio company Harpoon Therapeutics to be -3-January 8, 2024 | finanznachrichten.deWith 40% ownership, Arix Bioscience plc (LON:ARIX) has piqued the interest of institutional investorsJanuary 8, 2024 | finance.yahoo.comArix Bioscience PLC: Publication of Circular and RTW Bio Prospectus -2-January 5, 2024 | finanznachrichten.dePublication of Circular and RTW Bio ProspectusJanuary 5, 2024 | markets.businessinsider.comArix Bioscience PLC: Update regarding timing of Proposed Scheme of ReconstructionDecember 22, 2023 | finanznachrichten.deUpdate regarding timing of Proposed Scheme of ReconstructionDecember 22, 2023 | markets.businessinsider.comPortfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass TrialDecember 8, 2023 | markets.businessinsider.comThorny case for Arix chief to answerDecember 4, 2023 | thetimes.co.ukArix Bioscience board’s Caribbean meeting left shareholders ‘flabbergasted’November 19, 2023 | thetimes.co.ukCorrection: Portfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common StockNovember 15, 2023 | finanznachrichten.deAcacia Research Corporation (NASDAQ:ACTG) Q3 2023 Earnings Call TranscriptNovember 14, 2023 | finance.yahoo.comQ3 2023 Acacia Research Corp Earnings CallNovember 14, 2023 | finance.yahoo.comAcacia Research Corp (ACTG) Reports Mixed Q3 Results Amid Strategic ShiftsNovember 13, 2023 | finance.yahoo.comBroker Peel Hunt Ditches Arix Over Terms of Takeover DealNovember 12, 2023 | msn.comBroker quits Arix over RTW takeoverNovember 10, 2023 | thetimes.co.ukDon’t swallow dog’s breakfast deal at Arix BioscienceNovember 9, 2023 | thetimes.co.ukArix Bioscience PLC ARIXNovember 5, 2023 | morningstar.comAmerican investment firm swoops for Arix BioscienceNovember 2, 2023 | thetimes.co.ukPortfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102November 1, 2023 | markets.businessinsider.comArix Bioscience PLC: Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102November 1, 2023 | finanznachrichten.deRTW Biotech agrees "immediately accretive" Arix Bioscience takeoverNovember 1, 2023 | lse.co.ukRTW Biotech to Buy Arix Bioscience Assets, Swelling PortfolioNovember 1, 2023 | marketwatch.comActimed Therapeutics Appoints Martin Walton as Chief Financial OfficerOctober 19, 2023 | markets.businessinsider.comArix Bioscience boss set to leave as wind-down loomsSeptember 27, 2023 | thetimes.co.ukArix Bioscience CEO Steps DownSeptember 27, 2023 | marketwatch.comStrategic review of Arix Bioscience after activist pressureJuly 30, 2023 | thetimes.co.ukArix Bioscience plc (LON:ARIX) is definitely on the radar of institutional investors who own 40% of the companyJuly 30, 2023 | finance.yahoo.comBiotech firm backed by Neil Woodford ponders wind-downJuly 13, 2023 | thetimes.co.ukArix Bioscience launches strategic review despite value increaseJuly 13, 2023 | lse.co.ukArix Announces Strategic ReviewJuly 13, 2023 | markets.businessinsider.comArix Bioscience Begins Strategic Review, Says Winding-Down Is an OptionJuly 13, 2023 | marketwatch.comPortfolio company Disc Medicine raises $157.8 million in public offeringJune 23, 2023 | uk.news.yahoo.comPortfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHAJune 9, 2023 | markets.businessinsider.comUnaudited NAV for May 2023June 9, 2023 | uk.movies.yahoo.comArix Bioscience PLC: Unaudited NAV for May 2023June 9, 2023 | finanznachrichten.deCorrection: Result of Annual General MeetingMay 24, 2023 | markets.businessinsider.comArix Bioscience PLC: Result of Annual General MeetingMay 24, 2023 | finanznachrichten.dePortfolio company Ensoma announces closing of Series B ExtensionMay 16, 2023 | markets.businessinsider.comArix Bioscience PLC: Portfolio company Ensoma announces closing of Series B ExtensionMay 16, 2023 | finanznachrichten.deArix Bioscience PLC: Unaudited NAV for April 2023May 12, 2023 | finanznachrichten.deIndependent Non-Executive Chairman of Arix Bioscience Picks Up 14% More Stock \May 5, 2023 | finance.yahoo.com Get Arix Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ARIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! ARIX Media Mentions By Week ARIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARIX News Sentiment▼0.000.46▲Average Medical News Sentiment ARIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARIX Articles This Week▼00▲ARIX Articles Average Week Get Arix Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ARIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Oxford Biomedica News Today PureTech Health News Today Bioventix News Today Avacta Group News Today hVIVO News Today Faron Pharmaceuticals Oy News Today Scancell News Today Futura Medical News Today Redx Pharma News Today e-therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:ARIX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arix Bioscience plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arix Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
